Desoximetasone Patent Expiration

Desoximetasone is Used for treating plaque psoriasis in patients 18 years of age or older. It was first introduced by Taro Pharmaceutical Industries Ltd in its drug Topicort Lp on Approved Prior to Jan 1, 1982. Another drug containing Desoximetasone is Topicort. 16 different companies have introduced drugs containing Desoximetasone.


Desoximetasone Patents

Given below is the list of patents protecting Desoximetasone, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Topicort US5990100 Composition and method for treatment of psoriasis Mar 24, 2018

(Expired)

Taro
Topicort US8277780 Stable liquid desoximethasone compositions with reduced oxidized impurity Sep 01, 2028 Taro
Topicort US8715624 Stable liquid desoximethasone compositions with reduced oxidized impurity May 26, 2026 Taro


A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Desoximetasone's patents.

Given below is the list recent legal activities going on the following patents of Desoximetasone.

Event Date Patent/Publication
Patent litigations
Payment of Maintenance Fee, 12th Year, Large Entity 02 Apr, 2024 US8277780(Litigated)
Payment of Maintenance Fee, 8th Year, Large Entity 08 Nov, 2021 US8715624(Litigated)
Payment of Maintenance Fee, 8th Year, Large Entity 02 Apr, 2020 US8277780(Litigated)
Payment of Maintenance Fee, 4th Year, Large Entity 27 Oct, 2017 US8715624(Litigated)
Change in Power of Attorney (May Include Associate POA) 09 Mar, 2017 US8715624(Litigated)
Email Notification 09 Mar, 2017 US8715624(Litigated)
Email Notification 07 Mar, 2017 US8277780(Litigated)
Change in Power of Attorney (May Include Associate POA) 07 Mar, 2017 US8277780(Litigated)
Correspondence Address Change 07 Mar, 2017 US8715624(Litigated)
Correspondence Address Change 06 Mar, 2017 US8277780(Litigated)



Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳

Desoximetasone Generics

Several generic applications have been filed for Desoximetasone. The first generic version for Desoximetasone was by Taro Pharmaceutical Industries Ltd and was approved on Nov 30, 1990. And the latest generic version is by Cosette Pharmaceuticals Inc and was approved on Mar 4, 2020.

Given below is the list of companies who have filed for Desoximetasone generic.


1. NOVEL LABS INC

Novel Laboratories Inc has filed for 1 generic for Desoximetasone. Given below are the details of the strengths of this generic introduced by Novel Labs Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.25% ointment Prescription TOPICAL AB May 10, 2016


2. FOUGERA PHARMS

Fougera Pharmaceuticals Inc has filed for 1 generic for Desoximetasone. Given below are the details of the strengths of this generic introduced by Fougera Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.25% ointment Prescription TOPICAL AB Sep 28, 2012


3. TARO

Taro Pharmaceutical Industries Ltd has filed for 2 different strengths of generic version for Desoximetasone. All of these versions come by the name TOPICORT. Given below are the details of the strengths of this generic introduced by Taro.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.05%

(reference standard)

gel Prescription TOPICAL AB Jul 14, 1998
0.25% ointment Discontinued TOPICAL N/A Jun 7, 1996


4. LUPIN

Lupin Inc has filed for 2 different strengths of generic version for Desoximetasone. Given below are the details of the strengths of this generic introduced by Lupin.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.25% spray Prescription TOPICAL AT Mar 16, 2018
0.05% cream Prescription TOPICAL AB Jan 10, 2017


5. ALTANA

Altana Inc has filed for 1 generic for Desoximetasone. Given below are the details of the strengths of this generic introduced by Altana.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.25% ointment Discontinued TOPICAL N/A Apr 1, 1998


6. ACTAVIS MID ATLANTIC

Actavis Mid Atlantic Llc has filed for 1 generic for Desoximetasone. Given below are the details of the strengths of this generic introduced by Actavis Mid Atlantic.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.25% ointment Prescription TOPICAL AB Nov 7, 2016


7. RISING

Rising Pharma Holdings Inc has filed for 2 different strengths of generic version for Desoximetasone. Given below are the details of the strengths of this generic introduced by Rising.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.05% cream Prescription TOPICAL AB Dec 21, 2018
0.25% cream Prescription TOPICAL AB Jul 2, 2018


8. THE J MOLNER

The J Molner Co Ou has filed for 1 generic for Desoximetasone. Given below are the details of the strengths of this generic introduced by The J Molner.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.05% ointment Prescription TOPICAL AB Oct 23, 2018


9. SAPTALIS PHARMS

Saptalis Pharmaceuticals Llc has filed for 2 different strengths of generic version for Desoximetasone. Given below are the details of the strengths of this generic introduced by Saptalis Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.25% cream Discontinued TOPICAL N/A Jun 12, 2015
0.05% cream Discontinued TOPICAL N/A Jan 6, 2017


10. COSETTE

Cosette Pharmaceuticals Inc has filed for 1 generic for Desoximetasone. Given below are the details of the strengths of this generic introduced by Cosette.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.25% cream Discontinued TOPICAL N/A Mar 4, 2020


11. EPIC PHARMA LLC

Epic Pharma Llc has filed for 2 different strengths of generic version for Desoximetasone. Given below are the details of the strengths of this generic introduced by Epic Pharma Llc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.05% gel Prescription TOPICAL AB Mar 10, 2011
0.25% ointment Prescription TOPICAL AB Apr 24, 2014


12. PADAGIS US

Padagis Us Llc has filed for 1 generic for Desoximetasone. Given below are the details of the strengths of this generic introduced by Padagis Us.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.05% gel Prescription TOPICAL AB Jan 9, 2006


13. ZYDUS LIFESCIENCES

Zydus Lifesciences Ltd has filed for 1 generic for Desoximetasone. Given below are the details of the strengths of this generic introduced by Zydus Lifesciences.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.25% cream Prescription TOPICAL AB Sep 28, 2018


14. PAI HOLDINGS PHARM

Pai Holdings Llc Dba Pharmaceutical Associates Inc has filed for 1 generic for Desoximetasone. Given below are the details of the strengths of this generic introduced by Pai Holdings Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.25% ointment Discontinued TOPICAL N/A Feb 25, 2016


15. GLENMARK PHARMS LTD

Glenmark Pharmaceuticals Ltd has filed for 1 generic for Desoximetasone. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.25%

(reference standard)

ointment Prescription TOPICAL AB Sep 20, 2013


16. PADAGIS ISRAEL

Padagis Israel Pharmaceuticals Ltd has filed for 1 generic for Desoximetasone. Given below are the details of the strengths of this generic introduced by Padagis Israel.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.25% spray Prescription TOPICAL AT Jan 20, 2017